There are currently 127 active clinical trials seeking participants for Multiple Sclerosis research studies. The states with the highest number of trials for Autism participants are New York, Florida, California and Ohio.
Low-Load Blood Flow Restriction on Patients With Multiple Sclerosis
NCT05177952
Recruiting
This research is being done to compare the current standard of care for strength training for patients with Multiple Sclerosis to lightweight resistance training with blood flow restriction.
Gender:
Female
Ages:
Between 18 years and 55 years
Trial Updated:
12/15/2021
Locations: University of Central Florida, Orlando, Florida
Conditions: Training Study, Multiple Sclerosis, Blood Flow Restriction
Register for Updates
COVID-19 Vaccine Biomarker Study in Multiple Sclerosis
NCT05121662
Recruiting
SARS CoV-2 is the virus responsible for the pandemic COVID-19, which has resulted in nearly five million deaths worldwide since its spread in the beginning of 2020. In the United States, there are now two emergency use authorized vaccines that make use of messenger ribonucleic acid (mRNA) based technology that are highly effective for preventing COVID. However, because multiple sclerosis is an autoimmune condition, many individuals with multiple sclerosis take medicines that affect the immune sy... Read More
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
11/12/2021
Locations: Columbia University Irving Medical Center, New York, New York
Conditions: Multiple Sclerosis, COVID-19
Register for Updates
Novel Assessment of Synaptic Density in Progressive MS
NCT04634994
Recruiting
The investigators propose to use the novel SV2a-PET ligand, [F-18]SDM-8 to assess synaptic density in progressive MS (including primary progressive multiple sclerosis (PPMS) and secondary progressive multiple sclerosis (SPMS)) as compared to relapsing-remitting multiple sclerosis (RRMS) patients and healthy controls, given its improved imaging characteristics and potential for large scale applicability. The specific aims of the study are: Aim 1: To compare the cortical and subcortical grey mat... Read More
Gender:
All
Ages:
Between 18 years and 60 years
Trial Updated:
07/20/2021
Locations: Brigham and Women's Hospital, Boston, Massachusetts
Conditions: Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis, Multiple Sclerosis
Register for Updates
Home Based Infusions for Ocrelizumab
NCT04650321
Recruiting
The goal is to assess the safety and effectiveness of home ocrelizumab infusion.
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
06/08/2021
Locations: Amerita, Centennial, Colorado
Conditions: Multiple Sclerosis
Register for Updates
Effects of Lutein Supplementation on Cognition and MPOD in Multiple Sclerosis Patients-
NCT04843813
Recruiting
The central hypothesis is that lutein supplementation will improve MPOD and cognition. Accordingly, the specific aims are to 1) to determine the process feasibility associated with participating in 4-month lutein supplementation trial; and 2) to investigate the scientific feasibility of 4-month daily lutein supplementation on biological markers of lutein status and cognitive function among persons with MS.
Gender:
All
Ages:
Between 18 years and 64 years
Trial Updated:
04/12/2021
Locations: University of Illinois at Urbana-Champaign, Urbana, Illinois
Conditions: Multiple Sclerosis
Register for Updates
Motor Skill Acquisition Between Individuals With Neurological Disorders and Healthy Individuals
NCT04503187
Recruiting
Stroke survivors frequently show persistent gait deficits in their chronic stages even after years of intensive rehabilitation. This may be caused by diminished capability of re-acquiring motor skills post stroke. Thus, the overall purpose of this research project is to examine stroke survivors' capability of learning a novel leg task over 3 visits, 1-2 weeks apart. The capability of learning a new skill is then correlated with the individual's neurological functions (nerve activity and movement... Read More
Gender:
All
Ages:
Between 21 years and 90 years
Trial Updated:
08/03/2020
Locations: Texas Woman's University, Houston, Texas
Conditions: Stroke, Multiple Sclerosis
Register for Updates
Complementary and Alternative Care in Multiple Sclerosis
NCT01703429
Recruiting
This is a prospective, observational study designed to describe disease progression, symptom change, quality of life, diet and lifestyle habits, and frequency of adverse events among patients with multiple sclerosis (MS) who use complementary and alternative medicine (CAM). In addition to describing the patterns of CAM use, this study will also identify and describe the positive deviants, those individuals with the highest quality of life and least amount of disease activity. Positive deviants w... Read More
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
02/07/2020
Locations: Bastyr University Clinical Research Center, Kenmore, Washington
Conditions: Multiple Sclerosis
Register for Updates